Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,063
Award facts
- Contract value 100% obligated
- $17,063.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,063.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units). This non-set-aside award was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The contract represents a standard pharmaceutical supply delivery executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting Department of Defense healthcare requirements. As the prime contractor on the DLA Troop Support Medical IDC, AmerisourceBergen supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare systems and veteran facilities. XELJANZ XR, a branded immunosuppressant medication, represents the type of specialty pharmaceutical product regularly procured through this vehicle to support the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F9GY1?
SPE2DR26F9GY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9GY1 worth?
The government has obligated $17,063 on SPE2DR26F9GY1.
Is contract SPE2DR26F9GY1 an order under another contract?
Yes. SPE2DR26F9GY1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GY1 competed?
The extent of competition for SPE2DR26F9GY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award